REFINE-Lung: A Multicentre Phase III Study to Determine the Optimal Frequency of Pembrolizumab in Non-Small Cell Lung Cancer Utilising a Novel Multi-Arm Design. Ehsan Ghorani , Matteo Quartagno , Fiona Blackhall , Mary O'Brien , Christian Ottensmeier , Elena Pizzo , James Spicer , Duncan Gilbert , Alex Baker , Philip Badman , Charlotte Milner-Watts , D. Paolo d'Arienzo , Adam Dangoor , Jason Adhikaree , Joanne Evans , Pollyanna Leite , Manjusha Keni , Nicola Steele , Fabio Gomes , Igor Gomez-Randulfe , Petru Belitei , Grant Stewart , Colin Barrie , Tom Geldart , Pooja Jain , Liu K. H. Justin , Ishtaiq Zubairi , Dakshinamoorthy Muthukumar , Lucy Gray , Sarah Treece , Aleksandar Aleksic , Georgios Tsaknis , Emma Rathbone , Paul Shaw , Kathryn Tarver , K. B. Mahesh , Michael J. Seckl Lung Cancer（2024）
Key words
Non-Small Cell Lung Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
